The molecular mechanisms of ferroptosis and its role in glioma progression and treatment.
combination therapy
ferroptosis
glioma progression
molecular mechanism
role
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
04
2022
accepted:
05
07
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
Ferroptosis is one of the programmed modes of cell death that has attracted widespread attention recently and is capable of influencing the developmental course and prognosis of many tumors. Glioma is one of the most common primary tumors of the central nervous system, but effective treatment options are very limited. Ferroptosis plays a critical role in the glioma progression, affecting tumor cell proliferation, angiogenesis, tumor necrosis, and shaping the immune-resistant tumor microenvironment. Inducing ferroptosis has emerged as an attractive strategy for glioma. In this paper, we review ferroptosis-related researches on glioma progression and treatment.
Identifiants
pubmed: 36091118
doi: 10.3389/fonc.2022.917537
pmc: PMC9450584
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
917537Informations de copyright
Copyright © 2022 Lu, Zhou, Sun, Shafi, Ahmad, Sun and Dong.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Bioengineered. 2021 Dec;12(2):12636-12645
pubmed: 34927544
Cell Death Dis. 2022 Jan 21;13(1):73
pubmed: 35064112
EBioMedicine. 2021 Sep;71:103560
pubmed: 34482070
Cell Biosci. 2022 Feb 25;12(1):20
pubmed: 35216629
Free Radic Res. 2021 Jul;55(7):853-864
pubmed: 34323631
Oncogene. 2017 Oct 5;36(40):5593-5608
pubmed: 28553953
ACS Chem Biol. 2020 Feb 21;15(2):469-484
pubmed: 31899616
Free Radic Biol Med. 2020 May 20;152:175-185
pubmed: 32165281
Oxid Med Cell Longev. 2021 Feb 2;2021:8865791
pubmed: 33628389
Transl Oncol. 2020 Mar;13(3):100748
pubmed: 32087559
PLoS One. 2015 Feb 06;10(2):e0116644
pubmed: 25658639
Commun Biol. 2020 Aug 17;3(1):450
pubmed: 32807853
Redox Biol. 2020 Feb;30:101413
pubmed: 31896509
Pathol Res Pract. 2017 Jun;213(6):626-633
pubmed: 28552540
CA Cancer J Clin. 2020 Jul;70(4):299-312
pubmed: 32478924
Signal Transduct Target Ther. 2021 Jun 18;6(1):244
pubmed: 34145214
Biosci Rep. 2020 Jun 26;40(6):
pubmed: 32452511
Nat Chem Biol. 2017 Jan;13(1):91-98
pubmed: 27842070
Invest New Drugs. 2021 Aug;39(4):1123-1131
pubmed: 33506324
Front Cell Dev Biol. 2020 Jul 09;8:538
pubmed: 32733879
Nature. 2019 Nov;575(7784):693-698
pubmed: 31634899
Food Funct. 2021 Oct 19;12(20):9583-9606
pubmed: 34542140
Int J Mol Sci. 2021 Nov 22;22(22):
pubmed: 34830491
Comput Struct Biotechnol J. 2021 Aug 14;19:4603-4618
pubmed: 34471502
J Hematol Oncol. 2019 Mar 29;12(1):34
pubmed: 30925886
Oncol Rep. 2020 Jan;43(1):147-158
pubmed: 31789401
Trends Cell Biol. 2020 Jun;30(6):478-490
pubmed: 32413317
Biomaterials. 2021 Nov;278:121163
pubmed: 34601197
Oxid Med Cell Longev. 2021 Oct 23;2021:5005136
pubmed: 34725564
Protein Cell. 2021 Nov;12(11):836-857
pubmed: 33891303
Front Oncol. 2020 Jun 23;10:897
pubmed: 32656078
Cell Death Differ. 2019 Jan;26(1):14-24
pubmed: 30082768
Free Radic Biol Med. 2019 Mar;133:130-143
pubmed: 30268886
Nat Commun. 2020 Oct 27;11(1):5424
pubmed: 33110073
Front Immunol. 2020 Jul 17;11:1402
pubmed: 32765498
Free Radic Biol Med. 2019 Mar;133:162-168
pubmed: 29800655
Anticancer Drugs. 2020 Jan;31(1):27-34
pubmed: 31490283
J Hematol Oncol. 2020 Aug 10;13(1):110
pubmed: 32778143
Neuro Oncol. 2022 Jul 1;24(7):1113-1125
pubmed: 35148413
Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282
pubmed: 33495651
IUBMB Life. 2021 Feb;73(2):398-407
pubmed: 33372372
Oncogenesis. 2017 Aug 14;6(8):e371
pubmed: 28805788
Oncotarget. 2016 Nov 15;7(46):74630-74647
pubmed: 27612422
Apoptosis. 2021 Apr;26(3-4):152-162
pubmed: 33713214
Ann Transl Med. 2022 Mar;10(6):368
pubmed: 35434035
Cell Signal. 2021 Feb;78:109874
pubmed: 33285240
Oncol Lett. 2020 Oct;20(4):122
pubmed: 32863935
Acta Neuropathol Commun. 2021 Apr 14;9(1):67
pubmed: 33853689
Cell Death Dis. 2018 Aug 6;9(8):841
pubmed: 30082680
Oncoimmunology. 2020 Dec 29;10(1):1862949
pubmed: 33457081
Life Sci. 2020 Apr 15;247:117425
pubmed: 32057904
Neuro Oncol. 2017 Oct 19;19(11):1435-1446
pubmed: 28575312
Cell Death Discov. 2021 Oct 23;7(1):311
pubmed: 34689169
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Oncol Rep. 2015 Mar;33(3):1465-74
pubmed: 25585997
Acta Pharmacol Sin. 2021 Oct;42(10):1690-1702
pubmed: 34112960
Nature. 2019 Nov;575(7784):688-692
pubmed: 31634900
Mol Neurobiol. 2020 May;57(5):2461-2478
pubmed: 32152825
Genes Dev. 2020 Apr 1;34(7-8):526-543
pubmed: 32079652
Oncogene. 2021 Feb;40(8):1425-1439
pubmed: 33420375
Nature. 2021 May;593(7860):586-590
pubmed: 33981038
Cell Death Dis. 2020 Feb 3;11(2):88
pubmed: 32015325
Int J Mol Sci. 2020 Nov 09;21(21):
pubmed: 33182266
Semin Cancer Biol. 2020 Nov;66:89-100
pubmed: 30880243
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970